Israel’s SuperDimension Device Maker Attracts $300 Million Covidien Bid
This article was originally published in PharmAsia News
Israel’s SuperDimension has been offered $300 million by Ireland-base device maker Covidien for access to two devices designed for minimally invasive surgery.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.